Cooke Julie — SEC insider filings
SEC reporting owner CIK 1776977. 35 insider filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2020-08-07 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 50 legs across 27 filings — 153,847 shares, $20,063,918 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 57.
- Largest priced transaction: sale of 14,214 shares @ $154.83 ($2,200,685) in NEUROCRINE BIOSCIENCES INC, filed 2026-06-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Human Resources Officer | 35 | — | 50 legs · 153,847 sh · $20,063,918 | 57 |
Insider filings — Cooke Julie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 3,587 @ $0 · Tax withholding (F): 1,936 @ $156.22 | EDGAR |
| 2026-06-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 24,965 @ $81.49 · Sale (S): 14,214 @ $154.83 · Sale (S): 5,466 @ $155.46 · Sale (S): 4,216 @ $156.77 · Sale (S): 9,521 @ $157.62 · Sale (S): 3,520 @ $158.59 · +1 more | EDGAR |
| 2026-02-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,387 @ $0 · Tax withholding (F): 749 @ $123.10 · Option exercise (M): 1,401 @ $0 · Tax withholding (F): 756 @ $124.12 · Option exercise (M): 1,510 @ $0 · Tax withholding (F): 815 @ $124.12 · +7 more | EDGAR |
| 2026-02-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,741 @ $0 · Tax withholding (F): 997 @ $136.06 · Option exercise (M): 1,741 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 6,468 @ $61.82 · Option exercise (M): 6,468 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,509 @ $0 · Sale (S): 796 @ $116.77 · Option exercise (M): 1,401 @ $0 · Sale (S): 755 @ $116.80 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 5,548 (derivative) @ $0 · +2 more | EDGAR |
| 2025-02-12 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,329 @ $0 · Sale (S): 700 @ $118.28 · Option exercise (M): 1,329 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,740 @ $0 · Sale (S): 916 @ $152.89 · Sale (S): 824 @ $152.89 · Option exercise (M): 1,740 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 12,632 @ $61.82 · Sale (S): 12,632 @ $153.26 · Option exercise (M): 12,632 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 900 @ $61.82 · Sale (S): 900 @ $150.04 · Option exercise (M): 900 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 10,000 @ $61.82 · Sale (S): 10,000 @ $140.19 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 796 @ $133.04 · Grant/award (A): 28,161 (derivative) @ $0 · Grant/award (A): 5,604 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 640 @ $142.17 · Sale (S): 575 @ $141.96 · Sale (S): 700 @ $134.23 · Sale (S): 629 @ $136.78 | EDGAR |
| 2024-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 916 @ $140.70 · Sale (S): 824 @ $141.94 | EDGAR |
| 2023-12-27 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 14,000 @ $81.05 · Sale (S): 14,000 @ $129.99 · Option exercise (M): 10,000 @ $61.82 · Sale (S): 10,000 @ $126.79 · Option exercise (M): 14,000 (derivative) @ $81.05 · Option exercise (M): 10,000 (derivative) @ $61.82 | EDGAR |
| 2023-09-06 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 824 @ $110.93 | EDGAR |
| 2023-08-23 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 2,132 @ $107.41 | EDGAR |
| 2023-05-03 | 4/A | NEUROCRINE BIOSCIENCES INC (NBIX) | Holdings only — no transactions reported | EDGAR |
| 2023-05-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 11,397 @ $103.89 | EDGAR |
| 2023-04-27 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 100 @ $103.82 | EDGAR |
| 2023-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 37,523 (derivative) @ $0 · Grant/award (A): 6,038 (derivative) @ $0 | EDGAR |
| 2023-02-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 640 @ $105.47 · Sale (S): 575 @ $104.28 · Sale (S): 913 @ $102.25 · Sale (S): 12,801 @ $102.41 · Sale (S): 822 @ $104.03 · Sale (S): 700 @ $103.95 · +1 more | EDGAR |
| 2023-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 916 @ $108.48 | EDGAR |
| 2022-11-10 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 5,592 @ $81.05 · Sale (S): 5,592 @ $124.99 · Option exercise (M): 5,592 (derivative) @ $81.05 | EDGAR |
| 2022-11-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,144 @ $81.05 · Sale (S): 1,144 @ $124.97 · Option exercise (M): 7,264 @ $81.05 · Sale (S): 7,264 @ $125.00 · Option exercise (M): 1,144 (derivative) @ $81.05 · Option exercise (M): 7,264 (derivative) @ $81.05 | EDGAR |
| 2022-08-09 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,816 @ $100 | EDGAR |
| 2022-06-29 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 754 @ $100 | EDGAR |
| 2022-02-09 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 605 @ $80.55 · Sale (S): 913 @ $80.73 · Sale (S): 640 @ $80.63 · Sale (S): 700 @ $79.56 | EDGAR |
| 2022-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 47,401 (derivative) @ $0 · Grant/award (A): 6,961 (derivative) @ $0 | EDGAR |
| 2021-10-06 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 987 @ $101.73 | EDGAR |
| 2021-03-29 | 4/A | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 35,035 (derivative) @ $0 | EDGAR |
| 2021-02-09 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 605 @ $113.86 · Sale (S): 425 @ $116.76 · Sale (S): 913 @ $116.72 · Grant/award (A): 31,880 (derivative) @ $0 · Grant/award (A): 5,314 (derivative) @ $0 | EDGAR |
| 2020-11-16 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 2,257 @ $90.73 | EDGAR |
| 2020-10-06 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 987 @ $95.26 | EDGAR |
| 2020-08-07 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 2,257 @ $118.91 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1776977 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs